$IVDA

Iveda Solutions, Inc.

0
2
0

No SEC Form 4 filings for $IVDA in the last 30 days.

See all $IVDA insider activity →
Low

Students will get hands-on experience with AI video tools as Abitronix brings them to the tri-state region.

Abitronix and Iveda (NASDAQ: IVDA) are expanding their partnership to bring AI video tools, including IvedaAI, to the tri-state region and academia. The initiative includes launching Abitronix Labs at Kean University, providing students with hands-on experience in AI and security technologies. The global video analytics market is projected to grow significantly, according to Iveda.

Biotech Pre-Market Pulse: LIMN, IVDA Surge; OTLK, VBIO Sink

In biotech pre-market trading, Liminatus Pharma (LIMN) rose about 72% after moving to Nasdaq Capital and receiving an extension to regain minimum bid-price compliance. Iveda Solutions (IVDA) gained about 30% on a partnership announcement with GlobalMed. LENSAR (LNSR) was up about 22% after reporting second-quarter results.

IVDA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning IVDA (Iveda Solutions, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.

Recent IVDA coverage spans financial news and market movers.

What's driving IVDA

AlphAI scores every news story that mentions IVDA with an AI model for sentiment and relevance, and aggregates insider trades from Iveda Solutions, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $IVDA

Score

Students will get hands-on experience with AI video tools as Abitronix brings them to the tri-state region.

Abitronix and Iveda (NASDAQ: IVDA) are expanding their partnership to bring AI video tools, including IvedaAI, to the tri-state region and academia. The initiative includes launching Abitronix Labs at Kean University, providing students with hands-on experience in AI and security technologies. The global video analytics market is projected to grow significantly, according to Iveda.

$LIMNMed

Biotech Pre-Market Pulse: LIMN, IVDA Surge; OTLK, VBIO Sink

In biotech pre-market trading, Liminatus Pharma (LIMN) rose about 72% after moving to Nasdaq Capital and receiving an extension to regain minimum bid-price compliance. Iveda Solutions (IVDA) gained about 30% on a partnership announcement with GlobalMed. LENSAR (LNSR) was up about 22% after reporting second-quarter results.

Related tickers